Morgan Stanley lowers NICE stock price target to $160 on AI investment costs

Investing.comTuesday, November 18, 2025 at 10:33:01 AM
  • Morgan Stanley has lowered its price target for NICE stock to $160 due to rising costs linked to AI investments. This decision highlights the financial challenges NICE faces as it navigates the evolving landscape of artificial intelligence technology.
  • The reduction in the stock price target signals a cautious outlook for NICE, potentially impacting investor confidence. As the company invests heavily in AI, the increased costs may affect its profitability and growth trajectory, prompting stakeholders to reevaluate their positions in the market.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Palo Alto Networks stock outlook positive ahead of Q3 earnings, Morgan Stanley says
PositiveFinancial Markets
Morgan Stanley has expressed a positive outlook for Palo Alto Networks ahead of its Q3 earnings report. The investment firm anticipates strong performance from the cybersecurity company, which may reflect positively on its stock value in the upcoming earnings announcement.
Morgan Stanley maintains Progressive stock rating despite strong growth
NeutralFinancial Markets
Morgan Stanley has reaffirmed its stock rating for Progressive, despite the company's strong growth performance. This decision reflects the investment firm's cautious approach to the stock, indicating a belief that the current valuation may not fully reflect the potential for future growth.
Ardian Is Said to Tap Morgan Stanley, Macquarie for GBA Exit
NeutralFinancial Markets
Ardian SAS has engaged Morgan Stanley and Macquarie Group Ltd. to facilitate a potential sale of GBA Group, a German laboratory services provider. The deal is estimated to be valued at approximately €1.5 billion ($1.7 billion), according to sources familiar with the situation. This move indicates Ardian's strategic decision to exit its investment in GBA Group, which could significantly impact the laboratory services market in Germany.
Sonida Senior Living price target raised to $28 from $26 at Morgan Stanley
PositiveFinancial Markets
Morgan Stanley has raised the price target for Sonida Senior Living from $26 to $28, reflecting a positive outlook for the company. This adjustment indicates increased confidence in Sonida's market performance and potential growth, as analysts reassess the company's financial health and market position. The new target suggests that Morgan Stanley expects Sonida to perform well in the upcoming period, which could attract more investor interest and support the company's stock price.
Aramark stock price target lowered to $43 by Morgan Stanley on revenue miss
NegativeFinancial Markets
Morgan Stanley has lowered its stock price target for Aramark to $43 following a revenue miss. This adjustment reflects concerns over the company's financial performance, indicating that it did not meet the expected revenue figures. The downgrade may impact investor confidence and the stock's market performance moving forward.
Morgan Stanley Sees Indian Stocks Beating Peers on Policy Push
PositiveFinancial Markets
Morgan Stanley predicts that Indian equities will outperform their emerging market peers in the coming year, driven by proactive government policy measures. This marks a significant shift from India's historical underperformance in the global market landscape. The investment firm highlights the potential for Indian stocks to capitalize on favorable economic conditions and policy initiatives aimed at boosting growth.